No profile data available.
Olema Pharmaceuticals, Inc. (OLMA) is a healthcare company in the breast cancer treatment drugs industry, based in San Francisco, United States, with about 150 full-time employees.
It reported revenue of $0 for fiscal year 2025, and net income of -$162.45 million. In Q2 2026 (the quarter ended June 30, 2026) revenue was $0. Its market capitalization was $684.23 million as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2025; market data as of October 9, 2026.
, a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for women's cancers.
Olema Pharmaceuticals reported $0 in revenue for fiscal year 2025. In Q2 2026 revenue was $0.
$684.23 million as of October 9, 2026.
Listed companies of a similar size in the same industry (breast cancer treatment drugs) include Celcuity Inc. (CELC), Puma Biotechnology, Inc. (PBYI), Greenwich LifeSciences, Inc. (GLSI), Odonate, Inc. (ODTC).